Peripheral blood stem cells (PBSCs) were mobilized in mice by treatment with cytosine-arabinoside on day 0, followed by the administration by injection of granulocyte colonystimulating factor for 4 days. There were remarkable increases in the numbers of cells with lineage-negative (Lin-) c-&it+ markers, cells with colony-forming unit-cell (CFU-C) and colony-forming unit-spleen (CFU-S) activities, and cells with marrow-repopulating ability (MFIA) in the extramedullary sites (the spleen, peripheral blood, and liver) on day 5, whereas the number of these immature hematopoietic cells decreased in the bone marrow (BM) on day 5. This finding suggests the mobilization of immature hematopoietic cells from the B M to the extramedullary sites. Three-color flow cytometric analyses showed that CD4 antigen was not expressed on the Lin-Sca-l+ cells in the mobilized PB cells LURIPOTENT HEMATOPOIETIC stem cells (P-P HSCs) have two characteristics: the capacity for eternal self-renewal and the ability to differentiate into all cell lineages, including lymphoid cells. The differentiation of PHSCs into committed progenitor cells is continuous and results in a hierarchical structure.'. ' Recently, there has been much interest in HSCs that are mobilized into the peripheral blood (PB) after chemotherapy andor stimulation with ~ytokines."~ However, it should be clarified as to whether PB stem cells (PBSCs) are the same P-HSCs as those present in the bone marrow (BM), because PBSCs are now used for gene therapy and allogeneic transplantati~n.~.'' To answer this question, we examined changes in the distribution and activity of immature hematopoietic cells after mobilization in mice with or without splenectomy. Splenectomy was performed because (1) some PBSCs may be mobilized from the spleen and (2) there may be changes in the distribution of mobilized cells after splenectomy, because it is conceivable that mobilized cells migrate into the spleen.
4:00 pm. G-CSF was diluted in phosphate-buffered saline (PBS) containing 0.1 % bovine serum albumin (BSA) before subcutaneous injection. Injections were administered at 9:00 am and 9:oO pm, and mice were killed 12 hours after the last injection.
PB was harvested from the orbital plexus under anesthesia. Approximately 1 mL of blood was collected per mouse and centrifuged over Lympholyte-M (density, 1.0875; Cedarlane, Homby, Ontario, Canada) to remove erythrocytes. All nucleated cells from the interface were collected, washed once with PBS containing 2% fetal calf serum (2% FCS-PBS), and resuspended in 2% FCS-PBS.
BM cells (BMCs) from the femurs and tibias were collected by flushing. Spleens were removed and mechanically dissociated. The single-cell suspensions were obtained by passing through a 21-gauge needle. Cells were washed once with cold 2% FCS-PBS and resuspended in 2% FCS-PBS.
Liver mononuclear cells were obtained as follows. The liver was slowly perfused by I O mL of warm (37°C) PBS containing 100 U/ Protocol of PBSC mobilization.
Isolation of hematopoietic cells.
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YAMAMOTO ET AL mL of collagenase typeIV (Sigma, St Louis, MO) to remove PB and digest the tissue. The liver was then excised, minced, and centrifuged over Lympholyte-M, and the mononuclear cells were then treated as described above.
The CFU-C assay was performed by culturing cells in 1 mL of 0.8% methylcellulose, 30% FCS, 1% BSA, 5 X IO-5 m o m 2-mercaptoethanol (2-ME), 100 U/ mL IL-3, and 2 U/mL Epo. The colonies consisting of 50 or more cells were scored under an inverted microscope after 7 days of culture. In some experiments, the cells were plated in designated hematopoietic growth factors and scored after 7 days on the basis of gross morphology as granulocyte-macrophage (colony-forming unit-granulocyte-macrophage [CFU-GM]), erythroid burst (burstforming unit-erythroid [BFU-E]), or mix (colony-forming unit granulocyte, erythroid, monocyte, megakaryocyte [CFU-GEMM]).
The CFU-S assay was performed by injecting limited numbers of test cells into the orbital cavity of four to eight lethally irradiated mice (850 cGy at 90 cGy/min). The spleens were removed 8 or 12 days later and fixed with Bouin's solution. Visible surface colonies were counted and scored as CFU-S. Control mice (irradiation only) showed no macroscopic spleen nodules on days 8 or 12.
The MRA was investigated using a method described previously.",'2 Briefly, 13 days after the injection of test cells into lethally irradiated mice, aliquots of their femurs were used for the CFU-C assays. The MRA was expressed as CFU-C colonies generated per femur of host mice per IO5 test cells injected.
Monoclonal antibodies (MoAbs) and labeling reagent. The following MoAbs were used for cell surface analyses and cell sorting: anti-B220 (RA3-6B2), anti-Mac-1 (M1170.15). anti-Gr-1 (RB6-8C5), anti-CD4 (YTS191.1 or RM4-4), antLCD8 (53.6.7). anti-CD3 (145-2C1 I), anti-CD5 (53-7.3), anti-Sca-l (Ly-6A/E), anti-c-kit (ACK-2 or 4; kind gifts of Dr Shm-ichi Nishikawa, Kyoto University, Kyoto, Japan), anti-H-2K" (030-1 lF), anti-Thy-1.2 (30-H12), anti-CD71 (C2), anti-VLA-4 (Rl-2), anti-LFA-l (M27/5.2), and anti-Pgp-1 (1M7) MoAbs. Most MoAbs were obtained as purified forms from PharMingen (San Diego, CA) or Caltag Laboratories (South San Francisco, CA). The MoAbs were used as fluoresceinated (FITC), biotinylated, phycoerythrinated (PE), or concentrated media conditioned by hybridoma cells. Biotinylated and unconjugated MoAbs were detected with PE-(Becton Dickinson, Mountain View, CA) or Cy-Chrome-streptavidin (PharMingen) and PE-antirat Ig (Caltag), respectively. Rhodamine 123 (Rh123; Molecular Probes, Inc, Eugene, OR) was used for labeling cells.
Cells ( lo6) were suspended in 25 pL of PBS with 2% FCS and 0.1% NaN, (staining buffer) and mixed with optimal concentrations of MoAbs or reagents for 30 minutes on ice. Staining of cells with Rh123 was performed as described." In most experiments, anti-B220, anti-Gr-1, anti-Mac-1, anti-CD4, and anti-CD8 MoAbs were used to obtain Lin-cells. To detect CD4 antigen on Lin-Sca-1' cells, anti-B220, anti-Gr-1, anti-Mac-1, anti-CD3, and anti-CD5 MoAbs were used. Following a protocol reported previo~sly,'~ we used a higher cancentration (XlOO) of CD4 MoAb (YTS191.1; 100 pg/mL) than that optimal for staining the thymus. Unstained cells or cells incubated with an isotype-matched Ab were used as negative controls. Stained cells were analyzed using a FACScan (Becton Dickinson). FACS analyses were performed to evaluate the frequency of Lin-c-kit' cells in the test cells and the other markers in Lin-c-kit' (or Lin-Sca-1 +) cells.
For FACS of Lin-c-kit'Sca-l+ cells, low-density ( 5 1.077) mobilized PB cells (PBCs) or BMCs were incubated for 30 minutes with a mixture of rat MoAbs against Gr-1, Mac-1, B220, CD4, and CD8 antigens. Cells bound to prewashed immunomagnetic heads (Dynabeads; Dynal Inc, Oslo, Norway) at a bead-to-cell ratio of 40: 1 were removed magnetically. The remaining Lin-cells were stained with Hematopoietic progenitor assays.
Fluorescence-activated cell sorter (FACS) analyses.
anti-c-kif MoAb and either anti-Sca-1 or anti-Thyl.2 MoAb. After completion of cell sorting with a FACStar (Becton Dickinson), reanalysis of sorted fractions indicated 290% purity. We used these sorted fractions for the colony-forming assays and electron microscopic studies. In electron microscopic studies, we used cells with 298% purity. In some experiments, as previously reported," cells k jpW(l"1 , or c-kit' (as shown Fig 3A) and then subjected to sorting to detect P-HSCs in the mobilized PBCs.
The sorted cells were fixed with 2% glutaraldehyde containing 0.1 m o m phosphate buffer (pH 7.4), followed by postosmification. After dehydration with graded ethanol, they were embedded in Epon (Oken Commercial Co, Ltd, Tokyo, Japan). Ultrathin sections prepared by a Porter-Blum ultramicrotome (Sorvall Inc, Newtown, CT) were observed using a Hitachi H-600 electron microscope (Hitachi, Ibaragi, Japan) after double staining with uranyl acetate and lead citrate.
Allogeneic PBSC transplantation. After mobilization, the PB on day 5 from B6 mice was collected using Nycoprep (density, 1.077: Nycomed, Oslo, Norway) to remove erythrocytes and neutrophils. Low-density mononuclear cells were collected and washed with 2% FCS-PBS. T cells were removed by treating the cells with anti-CD4 and anti-CD8 MoAbs plus rabbit complement. The recipient C3H mice were lethally irradiated with 9.0 Gy from a '"Co source and were injected with the T-cell-depleted PBCs (7 X 10') 1 day after irradiation. As a control, T-cell-depleted normal BMCs (1.5 X IO' cells) of B6 mice were transferred into irradiated C3H mice. The chimeric mice were maintained in a laminar flow isolator with acidified water (pH 2.5) and analyzed from 14 days to 24 weeks after transplantation. White blood cell (WBC) and platelet counts were determined using a hemocytometer. Hematocrit (Hct) levels were evaluated using a microhematocrit tube. Chimerism was determined by FACS analyses (donor B6 mice, H-2K"; recipient C3H mice, H2Kk). The chimeric mice (at least 3) were killed at 5, 12, and 24 weeks after transplantation. The BMCs were individually used for CFU-C and CFU-S assays: more than 30 mice were used for the CFU-S assay.
Each experiment was performed three or more times. Reproducible results were obtained, and representative data are, therefore, shown in the tables and figures.
in Lin-Sca-l+ fraction were arbitrarily divided to c-kit"'""""" J ~ cElectron microscopic study.
RESULTS
Time course in response to AraC and G-CSF. Three to eight nonsplenectomized or splenectomized C57BL/6 mice were treated with either AraC + G-CSF or carrier alone.
There were progressive increases in the nucleated cell counts (NCCs) and Lin-c-kit+ cells in the spleen, PB, and liver by day 5 (Fig 1) . Particularly in splenectomized mice, significant increases in the NCCs and Lin-c-kit+ cell counts were noted in the PB and liver; NCCs in the PB reached a maximum (approximately 8 X lo4 cells/pL) on day 5. However, the increase in NCCs of the PB was mostly due to an increase in granulocytes (60% to 80% of the NCCs). The frequency of Lin-c-kit' cells in the PB on day 5 was low (02% to 0.3%) despite splenectomy. After ceasing the administration of G-CSF, the NCCs in the spleen, PB, and liver decreased sharply from day 5 to 9. In the BM, Lin-c-kit' cells decreased on day l , increased on day 3 (to an almost normal level), and then decreased again. These Lin-c-kit' cells maintained low levels until day 9 despite the increasing NCCs. Control mice that were injected with 0.1 % BSA (carrier of G-CSF) showed no change in the distribution of these cells in the various tissues irrespective of splenectomy (data not shown).
The percentages of CFU-C and CFU-S on day 12 in the extramedullary sites increased 20-to 80-fold on day 5 (Table l) , although those in the BM decreased to approximately half. In the splenectomized mice, slightly more CFU-C and CFU-S per lo5 cells were detected in the PB and liver (data not shown).
MRA assays were performed to evaluate more immature hematopoietic cells, because it has been reported that MRA reflects activities of pre-CFU with low activities of CFU-C and CFU-S." As shown in Fig 2, on day 0 (before treatment), cells with MRA were found mainly in the BM but some were found in the spleen, whereas there were very few cells with MRA in the PB and liver. However, 5 days after treatment, a higher MRA was found in the spleen, PB, and liver than in the BM. The PBCs on day 5 showed a lower activity in MRA than the BMCs on day 0 (normal BMCs), probably due to the marked increase in granulocytes in the PB.
Surface markers of immature hematopoietic cells in mobilized PBCs and BMCs. To examine the differences between immature hematopoietic cells (Lin-Sca-1 ' or Lin-c-kit+ cells) in mobilized PBCs and normal BMCs, three-color flow cytometric analyses were performed. Phenotypic analyses of these immature PBCs in nonsplenectomized and splenectomized mice showed similar characteristics. Among Lin-Sca-1' cells, mobilized PBCs expressed slightly lower levels of VLA-4, LFA-1, and ckit antigens (Ags) than did normal BMCs, although the level of Pgp-1 was similar to that of normal BMCs ( Fig   Frequency of blood progenitor cells. 3A). Lin-Sca-l+ cells in mobilized PBCs did not express CD4 Ag, although those in BMCs showed a low CD4 expression (Fig 3B) .
In the same way, among Lin-c-kit+ cells, we compared mobilized PBCs with normal BMCs to examine the differences in hierarchical composition (Fig 3C) . Both these cells displayed a high level of H-2K Ags. The frequency of cells expressing Sca-1 or Thy-1.2 Ag in Lin-c-kit' cells was higher in mobilized PBCs (about 60%) than in BMCs (about 20%). It is thought that CD71 Ag (transferrin receptor antigen) is expressed mostly on erythroid progeny, and that it is expressed more in proliferating cells than in quiescent cells." Less than 10% of Lin-ckit' cells in mobilized PBCs expressed CD7 1 Ag, whereas greater than 20% of these cells in BMCs expressed CD71 Ag. Mobilized PBCs showed lower fluorescent intensity in Rh123 staining than did BMCs, ie, 37.6% in the mobilized PBCs and 26.0% in the BMCs was Rh123d"i'. Thus, Lin-c-kit+ cells of mobilized PBCs showed more immature phenotypes than did those of BMCs.
Hematopoietic activity of Lin-c-kit'Sca-1 +(Thyl.2'") cells in mobilized PBCs. Because of the threefold higher frequency of Sca-1' or Thyl.2'" populations in Lin-ckit+ ceHs of mobilized PBCs, we examined whether these fractions have primitive hematopoietic activity. As shown in Table 2A , 20% to 30% of the Sca-1' or Thyl.2" population formed CFU-C colonies in the presence of IL-3 and Epo, and about 60% of Sca-l+ cells formed colonies in the presence of IL-3, SCF, IL-6, and Epo. In contrast, 10% to 20% of Sca-1-cells formed colonies in the pres- I T studies showed that the greater part (80% to 90%) of this population was a relatively heterogeneous population and that the cells had a somewhat abundant cytoplasm and a round to kidney-shaped nucleus with slightly condensed chromatin only at the nuclear membrane and small marginal nucleoli (Fig 4B) . The cytoplasm contained many mitochondria, several cisternae of endoplasmic reticulum (ER), free ribosome, Golgi apparatus, and a granule-like structure. These structural features suggest that most Lin-c-kit+Sca-1' cells of mobilized PBCs are cells in the cycling phase (relatively high metabolic state), but not in the Go phase (the dormant state). However, the remaining cells (10% to 20%) of this population had a round nucleus with very little peripheral chromatin condensation and a thin rim of cytoplasm with poorly developed organelles (Fig 4C) . Mitochondria were present but were not highly developed.
Allogeneic PBSC transplantation. Long-term reconstituting ability (LTRA) was assessed using mobilized PBCs of C57BL16J. After collecting the low-density PB from B6 mice on day 5 after AraC + G-CSF treatment, T cells were removed using anti-CD4 and CD8 MoAbs plus rabbit complement; this resulted in a reduction in T cells (CD4' and CD8+ cells) from 18% to 6%. These mobilized PBCs (PBSCs; 7 X lo6) were transferred into lethally irradiated C3H mice. The PBSCs (7 X lo6) contained Lin-c-kit+ cell counts equivalent to 1 to 2 X lo7 normal BMCs, which are capable of reconstituting allogeneic recipients.
The Hct level remained more or less in the normal range from 2 to 24 weeks after PBSC transplantation (Fig 5) . The WBC and platelet counts gradually increased 2 weeks after transplantation, and the WBC counts remained high (15,OOO to 20,000/pL) from 8 to 24 weeks. Leukocytosis was also seen in the chimeric mice after BMC transplantation.
The survival rate of [ B W 3 H ] chimeric mice after PBSC transplantation was 84% 24 weeks after transplantation; this rate was not significantly different from that of BMC transplantation (Fig 6) . No obvious symptoms of GVHD were detected.
H were almost all derived from the donors even 24 weeks after transplantation (Fig 7A) On flow cytometric analyses using the BMCs of [B6<3H] mice, Lin-c-kit' and Lin-Sca-1 + cells were mostly donor-derived (approximately 99% and 96%, respectively) even 24 weeks after transplantation (Fig 7B) . The BMCs in chimeric mice from 5 to 24 weeks after transplantation had almost the same CFU-C counts as normal BMCs (Fig 8) . The CFU-S counts gradually increased from 5 to 24 weeks. Although the ratio of CFU-S on day 12 to day 8 wa5 0.61 at 5 weeks, this ratio increased to 1.04 at 12 weeks, and the CFU-S counts on day 12 had reached near normal levels by 24 weeks (Fig 8) , indicating the strong self-renewal capacity of PBSCs in chimeric mice.
DISCUSSION
In this study, we examined the changes in the distribution of mobilized hematopoietic cells in mice after AraC plus G- ence of IL-3 and Epo, but synergistic effects with SCF and IL-6 were not seen. The Sca-1-fraction showed higher BFU-E counts than the Sca-1' fraction (35.2% of Sca-1-cells v 4.1% of Sca-l+ cells). In the Sca-1' cells, the CFU-S counts were 5.0 on day 8 and 53.0 on day 12. On the other hand, in the Sca-1-cells, the CFU-S counts were 18.5 on day 8 and 3.2 on day 12. Thus, the ratio of CFU-S counts on days 12 to 8 was higher in the Sca-l+ cells than in the Sca-1- (Table 2A) . These characteristics of the Sca-l+ or Sca-1-fraction in mobilized PBCs were compatible with those of the fractions in BMCs (Table 2B) , as described p r e v i o~s l y . '~~'~ Thyl.2'" cells formed more CFU-S counts on day 12 than on day 8, whereas Thy 1.2-cells (not Sca-1 -cells) had the considerable numbers of CFU-S on days 12. Greater enrichment of CFU-S on day 12 was obtained in the Sca-l+ cell population (Table  2A) . Thyl.2'" cells of the Lin-c-kit+ fraction in BMCs showed similar CFU-S activity to the cells in mobilized PBCs (Table 2B) .
It has recently been reported that P-HSCs are c-kit-or ckiP".I5,l9 We therefore attempted to examine the expression of c-kit antigen [c-kit-or c-kip] on primitive hematopoietic cells in the Lin-Sca-l+ fraction of the mobilized PBCs ( Fig  3A) . However, we failed to find any primitive cells with the c-kit-or c-kip marker; histology results showed that c-kit-. or c-kit"' cells in the mobilized PBCs were committed hematopoietic cells (data not shown).
Morphologic aspects of Lin-c-kit+Sca-I+ cells of mobilized PBCs. Lin-c-kit+Sca-l+ cells of mobilized PBCs showed a lymphoid-like appearance in morphology on MayGriinwald-Giemsa staining (Fig 4A) . A relatively scant cytoplasm, a large nucleus, and one to three smaller nucleoli were present in almost all of the cells. Electron microscopic 
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Lin CSF treatment; it is well known that AraC (a potent inhibitor of DNA synthesis extensively used in leukemic patients) elicits an active regenerative process after the initial marrow damage." AraC is a cytotoxic agent that injures the P-HSCs less than other cytotoxic drugs such as cyclophosphamide and busulfan.'' G-CSF has also been found to be an effective mobilizing fa~tor.'~ In the nonsplenectomized mice, there were remarkable increases in the numbers of cells with Lin-c-kit' markers, cells with CFU-C and CFU-S activities, and cells with MRA in the spleen, PB, and liver on day 5, whereas these immature hematopoietic cells decreased in the BM on day 5. In the BM, a transient increase in Lin-c-kit' cells was seen on day 3. This transient increase in Lin-ckit' cells in the BM was also shown in the SCF-treated mice." These results indicate the mobilization of HSCs and/ or progenitor cells from the BM to the PB rather than de novo generation of these cells within circulation blood. Grzegorzewski et aI2" directly showed the mobilization of CFU-GM and CFU-GEMM from the BM after in vivo injection of rhIL-7 into mice using 89 Sr. This is a P-emitting, bone-seeking radionuclide substituting for calcium molecules in the bone and selectively induces BM aplasia. In the splenectomized mice, the number of Lin-c-kit' cells in the PB or liver increased to a level 4 or 2 times higher, respectively, than in the nonsplenectomized mice. There are two possible roles of the spleen in the mobilization of PBSCs:
For personal use only. * L i d cells were removed from mobilized PBCs (A) or BMCs (B) using immunomagnetic beads. Sca-I-or Sca-I+ cells in the c-kit+ population were sorted. Thyl.2-or Thyl.2" cells were prepared similarly. CFU-C assays were performed in the presence of various cytokines at the concentrations as described in Material and Methods, and CFU-C counts were scored on day 7. CFU-S assays were performed using lethally irradiated 86 mice. Data are shown as the mean +. SD.
Abbreviation: ND, not done. 
CHARACTERIZATION OF MOUSE PBSCS
200-
150-
100
Weeks after Transplantation
For personal use only. on January 22, 2018. by guest www.bloodjournal.org From one is that some PBSCs may be mobilized from the spleen after AraC plus G-CSF treatment, and the other is that there may be changes in the distribution of mobilized hematopoietic cells after splenectomy, because it is conceivable that mobilized cells migrate into the spleen. Because the removal of the spleen leads to an increase in PBSC counts, the latter possibility is likely.
What are the mechanisms that govern the release of immature hematopoietic cells from the BM? The treatment with either various cytokines (SCF, G-CSF, GM-CSF, Epo, IL-1, IL-2, IL-3, IL-7, IL-8, etc), cytotoxic agents, or these combinations causes an increase in immature hematopoietic cells in the PB.26 14 Cytotoxic agents induce the sinus endothelial injury in the BM," which may facilitate the traffic of these cells into the extramedullary sites. In the present study, we have found that mobilized PBCs show slightly lower expressions of VLA-4, LFA-1, and c-kit in the Lin-Sca-l+ fraction than normal BMCs, although the expression of Pgp-1 was almost the same. VLA-4 and LFA-1 molecules are members of the PI and p2 integrin families of cell adhesion receptors and were shown to be expressed on immature hematopoietic cells and to be involved in the adhesion of these cells to BM stroma, although there is controversy as to whether LFA-1 is an absolute requirement for the early stage of hematopoiesis.'6 3y The c-kit Ag has been shown to play a major role in the adhesion of mast cells to fibroblasts4' and also of immature hematopoietic cells to stromal cell^.^' It is possible that the lower expression of these adhesion molecules (VLA-4, LFA-1, and c-kit) in the Lin-Sca-l+ fraction of mobilized PBCs reflects the mobilization of PHSCs and progenitor cells. This notion deserves serious consideration, because it was reported that intravenous injection with saturating amounts of anti-VLA-4 antibody into primates induced a modest increase in circulating WBCs and a significant mobilization of CFU-C and CD34+ cells.4z Furthermore, we have found that Lin-Sca-l+ cells in mobilized PBCs contain virtually no CD4+ cells, in contrast to those in normal BMCs. Previous studies showed that P-HSCs in the BM express a low level of CD4 Ag, but cells in the Bcell lineage or in the T-cell lineage lose CD4 Ag early after ~o m m i t m e n t . '~,~~ Although the function of CD4 Ag on PHSCs is not clearly defined, it is reported that CD4 plays a role in the interaction of hematopietic cells with their microenvironment via the Ia antigen, similar to mature T ~e l l s . 4~ Therefore, the absence of any CD4 Ag expression in the Lin-Sca-l+ cells of mobilized PBCs may reflect the mobilization of immature hematopoietic cells, as with the lower expression of adhesion molecules on mobilized PBCs.
We have found that Lin-c-kiP cells in mobilized PBCs contain more cells with Sca-l+, Thy1.2'", CD71-, and Rh123d"'i markers than those in the normal BMCs. Particularly, the number of Sca-l+ (Thyl.2'") cells in Lin-c-kiP population of mobilized PBCs was three times that in the BMCs. The Sca-1' cells in the mobilized PBCs formed more CFU-C colonies in the presence of IL-3, Epo, SCF, and IL-6, and also more CFU-S colonies on day 12 than Sca-1-cells. However, Thyl.2'" cells in mobilized PBCs or BMCs did not form as many CFU-S on day 12 as had Sca-l+ cells. This could be explained by the fact that P-HSC activity in the BM of Thylb-genotype mouse strain (B6, etc) was observed in both Thyl.2-and Thy 1.2" p0pulations.4~
In electron microscopy, most (80% to 90%) Lin-ckit+Sca-l+ cells in the mobilized PBCs had many organelles (mitochondria, rER, granule-like structure, etc). These morphologic characteristics of mobilized PBCs indicate a high metabolic state (cells in the cycling phase). These cells probably belong to committed progenitor cells. However, 10% to 20% of this population contained only a few organelles with a higher nuclear cytoplasmic ratio. The latter cells had a similar structure to the cells in WGAt fraction in the BM after 5-fluorouracil (5-FU) treatment (both in vivo and in vitro), although the nucleus of these WGA+ cells consists of more heterochromatin and fewer mitochondria!6 These cells probably show lower fluorescent intensity in Rh123 staining, which selectively stains mitochondrial membranes. It has also been reported that the Rh123'"Lin-c-kit+Sca-l+ cells in the BM are highly enriched for long-term repopulating cells (1 in 5 cells) and that 88% of the recipients of 10
For personal use only. on January 22, 2018. by guest www.bloodjournal.org From such cells show greater than 1 % donor cells in the peripheral blood at 26 weeks after transplantation?' We are in the process of characterizing the function of Rhl23'"Lin-ckit+Sca-1' cells in the mobilized PBCs by a competitive repopulation assay using Ly-5.1 and Ly-5.2 congenic mice. Previous studies have shown that c-kit Ag is highly expressed on P-HSCs and other progenitor cells in adult BMCs and fetal liver. 17. 48 However, in vivo blocking experiments using an antagonistic anti-c-kit MoAb (ACK-2) showed that a small but significant number of day 13 CFU-S, which were large mixed-type colonies, remained in the BM.49 It has also been shown that 5-FU-resistant dormant hematopoietic cells are c-kip." The lower expression of c-kit Ag on primitive hematopoietic cells was also reported in humans." We have very recently shown that only four Lin-H-2Khigh CD71-cells in the BMCs after 5-FU treatment produce donor-derived cells in primary recipients over an 8-month period after transplantation and that the cells yield repopulation with detectable levels of primary donor-derived cells in secondary recipient~.~" These P-HSCs were found to be Sca-l', Thyl'", but c-kit'" or c-kit-. We have just found that the 5-FTresistant P-HSCs in the G phase are c-kit-20*21; however, the P-HSCs show c-kit+ when the cells enter the cell cycle (manuscript in preparation). Although the Lin-Sca-1 that PBSCs have LTRA in the transplantation between congeneic animals. Hoever, it should be clarified whether these PBSCs can reconstitute allogeneic mice across MHC barriers. As we have shown in the present study, PBSCs had LTRA (24 weeks) in [B6<3H] chimeric mice, although longer (> 1 years) observation is necessary. In addition, the chimeric mice showed immunologic functions similar to mice that received BMCs, even 24 weeks after transplantation (Yamamoto et al, manuscript in preparation). This suggests the validity of allogeneic PBSC transplantation. Autografting with PBSCs has become almost routine in the management of selected patients with leukemia and some solid tumors due to two major advantages of autografting PBSCs: one is rapid neutrophil and platelet recovery, and the other is easy harvesting of PBSCs without the risk of general anesthesia. If mobilized PBCs contain P-HSCs, which can reconstitute even allogeneic hosts and do not induce severe GVHD, allogeneic PBSC transplantation can be expected to become a valuable strategy for the treatment of various diseases."'"
